Ah Equity Partners Lsv Ii, L.L.C. Eq Rx, Inc. Transaction History
Ah Equity Partners Lsv Ii, L.L.C.
- $95.6 Million
- Q3 2023
A detailed history of Ah Equity Partners Lsv Ii, L.L.C. transactions in Eq Rx, Inc. stock. As of the latest transaction made, Ah Equity Partners Lsv Ii, L.L.C. holds 5,000,000 shares of EQRX stock, worth $0. This represents 11.61% of its overall portfolio holdings.
Number of Shares
5,000,000
Previous 5,000,000
-0.0%
Holding current value
$0
Previous $9.3 Million
19.35%
% of portfolio
11.61%
Previous 9.64%
Shares
1 transactions
Others Institutions Holding EQRX
# of Institutions
7Shares Held
67.8MCall Options Held
0Put Options Held
0-
Ah Equity Partners Bio Iii, L.L.C. Menlo Park, CA19.2MShares$0100.0% of portfolio
-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA17.4MShares$060.15% of portfolio
-
Arboretum Ventures, Inc.13.9MShares$063.96% of portfolio
-
Ah Equity Partners Lsv I, L.L.C. Menlo Park, CA11.4MShares$08.42% of portfolio
-
Beaumont Financial Partners, LLC731KShares$00.35% of portfolio
About EQRx, Inc.
- Ticker EQRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 448,140,992
- Description
- EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...